Patent · US Active

CXCL8 binding nucleic acids

US12359206B2 · kind B2 · utility

0Cited by

2References

21Claims

0Family size

Assignee

Aptarion Biotech AG · DE

Inventors

Kai Hohlig · Berlin, DE
Axel Vater · Berlin, DE
Werner Purschke · Berlin, DE
Dirk Zboralski · Berlin, DE
Christian Maasch · Berlin, DE

Key dates

Filing date	Nov 12, 2019
Grant date	Jul 15, 2025
Priority date	—
Expiry date	Nov 11, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/5421
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention is related to an L-nucleic acid molecule capable of binding to human CXCL8, wherein the L-nucleic acid molecule comprises a central stretch of nucleotides, wherein the central stretch of nucleotides comprises a nucleotide sequence of 5′-GG A AGU ACGUGGA AAGCCRA(Xu)RAGUGUGUCCCG-3′[SEQ. ID. NO: 27], wherein Xu is U or absent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.